All Products

Hello Heart
Hello Heart

Hello Heart is a smartphone app that lets people track, understand and manage their blood pressure. Users are able to build healthy habits through personalized wellness tips. In turn, making healthy lifestyle changes may reduce a person's bloo [...]

Insulia
Insulia

Insulia®, available via mobile app or web portal, is a prescription-only medical device that recommends basal insulin doses for adults with Type 2 diabetes based on the treatment plan created by the healthcare provider.

Oleena
Oleena

Oleena® is a prescription mobile app for cancer patients, designed to help them in the management of their symptoms and enable remote monitoring by care teams.

Freespira
Freespira

Freespira is indicated (FDA-cleared) as an adjunctive treatment of symptoms associated with panic disorder, panic attacks and/or PTSD in patients 18 and older.

Luminopia One
Luminopia One

Luminopia™ One is an FDA Cleared prescription digital therapeutic indicated for improvement in visual acuity in amblyopia patients aged 4-7.

RelieVRx
RelieVRx

RelieVRx (formerly EaseVRx) is an FDA Cleared at-home immersive virtual reality (VR) pain treatment indicated as adjunctive treatment for chronic lower back pain (CLBP).

Mahana IBS
Mahana IBS

Mahana IBS is an FDA-cleared, clinically validated digital treatment for IBS. Apple App Store Rating: 4.7 (314 Reviews)

Nightware
Nightware

NightWare is an FDA cleared digital therapeutic to interrupt nightmares and improve sleep quality. Apple App Store Rating: 4.1 (11 Reviews)

Nerivio
Nerivio

Nerivio is a smartphone-controlled wearable, noninvasive device to relieve symptoms of a migraine that’s already started. The treatment is personalized through the Nerivio app, which also includes a migraine diary to track treatment sessions a [...]

EndeavorRx
EndeavorRx

EndeavorRx is a first-of-its-kind ADHD treatment for kids 8-12, delivered through an immersive video game experience on iPhone®, iPad® and Android™ devices.

reSET-O
reSET-O

reSET-O, the first PDT to receive Breakthrough Designation and authorized by FDA in December 2018, is an 84-day Prescription Digital Therapeutic (PDT) for Opioid Use Disorder (OUD).

reSET
reSET

reSET, the first Prescription Digital Therapeutic (PDT) to receive authorization from FDA to improve disease outcomes, is a 90-day PDT for Substance Use Disorder (SUD).

Product: Somryst
Product: Somryst

Somryst® is a prescription-only digital therapeutic intended to provide a neurobehavioral intervention (CBT-I) to patients 22 years of age and older with chronic insomnia. Apple App Store Rating: 4.1 (11 Reviews)